Infectious factors in atopic dermatitis, pharmaceutical possibilities (systematic literature review)

Close metadata

OBJECTIVE

To analyze the results of researches on infectious factors and possibilities of pharmaceutical impact in patients with AD.

MATERIAL AND METHODS

Search for articles was carried out in PubMed, Scopus, Google Scholar, E-library scientific databases by following keywords: infectious diseases, atopic dermatitis, immune responses.

RESULTS

Systemic immune responses are the basis of pathogenic relationship between AD and infectious diseases. Atopic march includes bronchial asthma, allergic rhinoconjunctivitis and/or food intolerance. In adulthood, AD may be manifested by eczematous lesions of the hands’ skin and allergic contact dermatitis. Epithelial barrier damage, increased concentrations of Th2/Th22 and cytokines, reduced levels of antimicrobial peptides, decreased bacterial diversity, prevalence of pathogens, as well as the use of immunosuppressive agents in therapy are the components of pathogenesis of allergic sensibilization and infectious pathology. Staphylococcus aureus is detected in 70—90% of cases in AD foci by bacteriological techniques, whereby some patients have predominantly methicillin-resistant S. aureus. A frequent presence of human papilloma virus, reduction of microbial diversity and colonies of Malassezia fungi are noted. Patients with AD have higher prevalence of infectious diseases of the visceral organs (streptococcal pharyngitis, upper and lower respiratory tract infections, recurrent otitis, varicella disease and urinary tract infections, esophagitis and gastritis).

CONCLUSION

AD is associated with the morbidity of both skin infectious diseases and most diseases of the visceral organs of infectious etiology, that should be considered in scientific and therapeutic diagnostic algorithms.

Keywords:

infectious factors

atopic dermatitis

pathogenesis

immune responses

Authors:

Konyshko N.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0002-6547-9425

Konyshko G.C.

Smolensk Regional Clinical Hospital

ORCID: 0009-0002-1915-1127

Matveeva D.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0009-0004-0302-5112

Volynets L.I.

Smolensk Regional Clinical Hospital;
Smolensk State Medical University

ORCID: 0000-0003-3937-7027

Kireeva A.A.

The Loginov Moscow Clinical Scientific Center

Received:

29.02.2024

Accepted:

20.11.2024

List of references:

Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;92:44e7.
Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021 Jan;126(1):3-12. https://doi.org/10.1016/j.anai.2020.08.002
Jonathan I. Silverberg. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123:144e151. https://doi.org/10.1016/j.anai.2019.04.020
Kim HS, Hwang HJ, Seo WD, Do SH. Sprouts Restore Skin Barrier Function by Modulating the Expression of the Epidermal Differentiation Complex in Models of Skin Irritation. Int J Mol Sci. 2023;24(24):17274. https://doi.org/10.3390/ijms242417274
Venkataraman D, Soto-Ramírez N, Kurukulaaratchy RJ, Holloway JW, Karmaus W, Ewart SL, Arshad SH, Erlewyn-Lajeunesse M. Filaggrin loss-of-function mutations are associated with food allergy in childhood and adolescence. J Allergy Clin Immunol. 2014 Oct;134(4):876-882.e4. https://doi.org/10.1016/j.jaci.2014.07.033
Berdyshev E, Goleva E, Bronova I, Dyjack N. Lipid abnormalities in atopic skin are driven by type 2 cytokines. JCI Insight. 2018;22;3(4):e98006. https://doi.org/10.1172/jci.insight.98006
Iwamoto K, Nümm TJ, Koch S, Herrmann N, Leib N, Bieber T. Langerhans and inflammatory dendritic epidermal cells in atopic dermatitis are tolerized toward TLR2 activation. Allergy. 2018;73(11):2205e2213.
Fyhrquist N, Muirhead G, Prast-Nielsen S, et al. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019;10(1):4703.
Kim J, Kim BE, Ahn K, Leung DYM. Interactions between atopic dermatitis and Staphylococcus aureus infection: clinical implications. Allergy Asthma Immunol Res. 2019;11(5):593e603.
Orfali RL, Yoshikawa FSY, Oliveira LMDS, et al. Staphylococcal enterotoxins modulate the effector CD4þ T cell response by reshaping the gene expression profile in adults with atopic dermatitis. Sci Rep. 2019;9(1):13082.
Orfali RL, da Silva Oliveira LM, de Lima JF, et al. Staphylococcus aureus enterotoxins modulate IL-22-secreting cells in adults with atopic dermatitis. Sci Rep. 2018;8(1):6665.
Stier MT, Peebles Jr RS. Innate lymphoid cells and allergic disease. Ann Allergy Asthma Immunol. 2017;119(6):480e488. https://doi.org/10.1016/j.anai.2017.08.290
Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347(15):1151e1160. https://doi.org/10.1056/NEJMoa021481
Simons E, Balshaw R, Lefebvre DL, Dai D, Turvey SE, Moraes TJ, Mandhane PJ, Azad MB, Sears MR, Subbarao P, Becker AB. Timing of Introduction, Sensitization, and Allergy to Highly Allergenic Foods at Age 3 Years in a General-Population Canadian Cohort. J Allergy Clin Immunol Pract. 2020;8(1):166-175.e10. https://doi.org/10.1016/j.jaip.2019.09.039
Ferrucci S, Casazza G, Zussino M, Tavecchio S, Marzano AV, Tedeschi M. Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis. J Clin Med. 2023;12(20):6575. https://doi.org/10.3390/jcm12206575
Kommoss KS, Bieler T, Ringen J, Lehmann A, Mihalceanu S, Hobohm L, Keller K, Brand A, Fischer B, Kramer D, Wild J, Waisman A, Enk A, Schäkel K, Heikenwälder M, Karbach S. A simple tool for evaluation of inflammation in psoriasis: NeutrophIL-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease. J Mol Med (Berl). 2023;12:4. https://doi.org/10.1007/s00109-023-02406-4
Wang V, Keefer M, Ong PY. Antibiotic choice and methicillin-resistant Staphylococcus aureus rate in children hospitalized for atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(3):314e317.
Pandaleke TA, Handono K, Widasmara D, Susianti H. The immunomodulatory activity of Orthosiphon aristatus against atopic dermatitis: Evidence-based on network pharmacology and molecular simulations. J Taibah Univ Med Sci. 2023;19(1):164-174. https://doi.org/10.1016/j.jtumed.2023.10.005
Mohamed AA, El Borolossy R, Salah EM, Hussein MS, Muharram NM, Elsalawy N, Khalil MG, Mahmoud MO, El-Amir RY, Elsanhory HMA, Ahmed N, Adaroas AS, Montaser M, El Kholy AA. A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children. Front Pharmacol. 2023;14:1202325. https://doi.org/10.3389/fphar.2023.1202325
Mack MR, Brestoff JR, Berrien-Elliott MM, et al. Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. Sci Transl Med. 2020;12(532):eaay1005.
Kader HA, Azeem M, Jwayed SA, Al-Shehhi A, Tabassum A, Ayoub MA, Hetta HF, Waheed Y, Iratni R, Al-Dhaheri A, Muhammad K. Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis. Cells. 2021 Jun 4;10(6):1392. https://doi.org/10.3390/cells10061392
Çetinarslan T, Kümper L, Fölster-Holst R.The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update. Front Mol Biosci. 2023;10:1159404. https://doi.org/10.3389/fmolb.2023.1159404
Chung HC, Keiller DR, Swain PM, Chapman SL, Roberts JD, Gordon DA.Responsiveness to endurance training can be partly explained by the number of favorable single nucleotide polymorphisms an individual possesses. PLoS One. 2023;18(7):e0288996. https://doi.org/10.1371/journal.pone.0288996
Schneeweiss MC, Kirchgesner J, Wyss R, Jin Y, York C, Merola JF, Mostaghimi A, Silverberg JI, Schneeweiss S, Glynn RJ. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology. Br J Dermatol. 2022;187(5):692-703. https://doi.org/10.1111/bjd.21704
Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci. 2021 Apr 16;22(8):4130. https://doi.org/10.3390/ijms22084130
Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol. 2021 Jan;126(1):3-12. https://doi.org/10.1016/j.anai.2020.08.002
Sun D, Ong PY. Infectious complications in atopic dermatitis. Immunol Allergy Clin North Am. 2017;37:75e93. https://doi.org/10.1016/j.iac.2016.08.015
Bosveld CJ, Guth C, Limjunyawong N, Pundir P. Emerging Role of the Mast Cell-Microbiota Crosstalk in Cutaneous Homeostasis and Immunity. Cells. 2023 Nov 14;12(22):2624. https://doi.org/10.3390/cells12222624
Chen YE, Fischbach MA, Belkaid Y. Skin microbiota-host interactions. Nature. 2018;553(7689):427-436. https://doi.org/10.1038/nature25177
Bjerre RD, Holm JB, Palleja A, Sølberg J, Skov L, Johansen JD. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus. BMC Microbiol. 2021.23;21(1):256. https://doi.org/10.1186/s12866-021-02302-2
Wang ZY, Zheng YX, Xu F, Cui YZ, Chen XY, Chen SQ, Yan BX, Zhou Y, Zheng M, Man XY. Epidermal keratinocyte-specific STAT3 deficiency aggravated atopic dermatitis-like skin inflammation in mice through TSLP upregulation. Front Immunol. 2023 Nov 20;14:1273182. https://doi.org/10.3389/fimmu.2023.1273182
Smits JPH, Ederveen THA, Rikken G, van den Brink NJM, van Vlijmen-Willems IMJJ, Boekhorst J, Kamsteeg M, Schalkwijk J, van Hijum SAFT, Zeeuwen PLJM, van den Bogaard EH. Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides. J Invest Dermatol. 2020;140(2):415-424.e10. https://doi.org/10.1016/j.jid.2019.06.142
Clowry J, Irvine AD, McLoughlin RM. Next-generation anti-Staphylococcus aureus vaccines: A potential new therapeutic option for atopic dermatitis? J Allergy Clin Immunol. 2019;143(1):78-81. https://doi.org/10.1016/j.jaci.2018.08.038
de Wit J, Totte JEE, van Buchem FJM, Pasmans S. The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2018; 178:1263e1271. https://doi.org/10.1111/bjd.16251
Bjerre RD, Bandier J, Skov L, Engstrand L, Johansen JD. The role of the skin microbiome in atopic dermatitis: a systematic review. Br J Dermatol. 2017;177:1272e1278. https://doi.org/10.1111/bjd.15390
Hsu UH, Chiang BL. γδ T Cells and Allergic Diseases. Clin Rev Allergy Immunol. 2023;65(2):172-182. https://doi.org/10.1007/s12016-023-08966-0
Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis. 2009;49(1):65e71.
Francis NA, Ridd MJ, Thomas-Jones E, et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann Fam Med. 2017;15(2):124e130.
Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134:818e23. https://doi.org/10.1016/j.jaci.2014.08.005
Hodara E, Ong PY.The Genetics of Eczema Herpeticum. Clin Rev Allergy Immunol. 2022;63(3):390-397. https://doi.org/10.1007/s12016-022-08953-x
Leung DY. Why is eczema herpeticum unexpectedly rare? Antiviral Res. 2013;98(2):153e157.
Moran MC, Klose A, Yoshida T, De Benedetto A, Schneider LC, Ong PY, Simpson EL, Leung DYM, Miller BL, Seplaki CL, Beck LA. History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis. Dermatol Ther (Heidelb). 2023;13(10):2417-2429. https://doi.org/10.1007/s13555-023-00996-y
Wollenberg A, Wetzel S, Burgdorf WH, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol. 2003;112(4):667e674.
Manti S, Amorini M, Cuppari C, et al. Filaggrin mutations and molluscum contagiosum skin infection in patients with atopic dermatitis. Ann Allergy Asthma Immunol. 2017;119(5):446e451.
von Kobyletzki L, Ballardini N, Henrohn D, Neary MP, Ortsäter G, Geale K, Rieem Dun A, Lindberg I, De Geer A, Neregård P, Cha A, Cappelleri JC, Romero W, Thyssen JP. Care pathways in atopic dermatitis: a retrospective population-based cohort study. J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1456-1466. https://doi.org/10.1111/jdv.18185
de Lusignan S, Alexander H, Broderick C, Dennis J, McGovern A, Feeney C, Flohr C. Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study. J Allergy Clin Immunol. 2022 Sep;150(3):709-713. https://doi.org/10.1016/j.jaci.2022.03.030
Galli E, Fortina AB, Ricci G, Maiello N, Neri I, Baldo E, Berti I, Bonamonte D, Capra L, Carboni E, Carello R, Caroppo F, Cavagni G, Chinellato I, Cipriani F, Comberiati P, Diociaiuti A, Di Lernia V, Duse M, Filippeschi C, Giannetti A, Giovannini M, Licari A, Marseglia GL, Pace M, Patrizi A, Pajno GB, Peroni D, Villani A, Eichenfield L. Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP). Ital J Pediatr. 2022;48(1):95. https://doi.org/10.1186/s13052-022-01278-7
Nakatsuji T, Gallo RL. The role of the skin microbiome in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(3):263e269.
Silverberg JI, Silverberg NB. Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study. J Allergy Clin Immunol. 2014;133:1041e1047. https://doi.org/10.1016/j.jaci.2013.08.012
Almenara-Blasco M, Carmona-Pírez J, Gracia-Cazaña T, Poblador-Plou B, Pérez-Gilaberte JB, Navarro-Bielsa A, Gimeno-Miguel A, Prados-Torres A, Gilaberte Y. Comorbidity Patterns in Patients with Atopic Dermatitis Using Network Analysis in the EpiChron Study. J Clin Med. 2022; 11(21):6413. https://doi.org/10.3390/jcm11216413
Strom MA, Silverberg JI. Association between atopic dermatitis and extracutaneous infections in US adults. Br J Dermatol. 2017;176:495e497. https://doi.org/10.1111/bjd.14708
Narla S, Hsu DY, Thyssen JP, Silverberg JI. Inpatientfinancial burden of atopic dermatitis in the United States. J Invest Dermatol. 2017;137: 1461e1467. https://doi.org/10.1016/j.jid.2017.02.975
Åkerlund S, Seifert O, Assarsson J, Jerkovic SG. Significant Association between Obsessive-Compulsive Disorder and Atopic Dermatitis — a Retrospective Population-Based Case-Control Study. Dermatol Pract Concept. 2023;13(1):e2023053. https://doi.org/10.5826/dpc.1301a53
Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1):10e22.e2.
Gong JQ, Lin L, Lin T, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155(4):680e687.
Seegräber M, Worm M, Werfel T, et al. Recurrent eczema herpeticum — a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients. J Eur Acad Dermatol Venereol. 2020;34(5):1074e1079.
Callewaert C, Nakatsuji T, Knight R, et al. IL-4Rablockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis. J Invest Dermatol. 2020;140(1):191e202.e7.
George SM, Karanovic S, Harrison DA, et al. Interventions to reduce Staphylococcus aureus in the management of eczema. Cochrane Database Syst Rev. 2019;2019(10):CD003871.
Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Disease Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285e292.
Renert-Yuval Y, Guttman-Yassky E. New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines. Ann Allergy Asthma Immunol. 2020;124(1):28e35.
Smits JPH, Ederveen THA, Rikken G, et al. Targeting the cutaneous microbiota in atopic dermatitis by coal tar via AHR-dependent induction of antimicrobial peptides. J Invest Dermatol. 2020;140(2):415e424.e10.
Nakagawa S, Hillebrand GG, Nunez G.Rosmarinus officinalis L.(Rosemary) extracts containing carnosic acid and carnosol are potent quorum sensing inhibitors of Staphylococcus aureusvirulence. Antibiotics (Basel). 2020;9(4):149.
Potekaev NN, Serov DN, Mikhailova IA, Anokhina LS, Fedotova KYu, Georgadze NG. Modern aspects of pathogenesis and therapy of atopic dermatitis. Russian Journal of Clinical Dermatology and Venereology. 2019;18(3): 259-263. (In Russ.). https://doi.org/10.17116/klinderma201918031259

Close metadata